Brian Edwin Cathers Global Blood Therapeutics, Inc. (GBT) insider trading activity

GBT Quotes by TradingView

Brian Edwin Cathers is Chief Scientific Officer of Global Blood Therapeutics, Inc.. Currently has a direct ownership of 12,005 shares of GBT, which is worth approximately $0. The most recent transaction as insider was on Mar 01, 2021, when has been sold 1,297 shares (Common Stock) at a price of $44.48 per share, resulting in proceeds of $57,691. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12K
0% 3M change
0% 12M change
Total Value Held $0

BRIAN EDWIN CATHERS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 01 2021
SELL
Payment of exercise price or tax liability
$57,691 $44.48 p/Share
1,297 Reduced 9.75%
12,005 Common Stock
Mar 01 2021
BUY
Exercise of conversion of derivative security
-
3,750 Added 21.99%
13,302 Common Stock
Feb 01 2021
SELL
Payment of exercise price or tax liability
$58,299 $49.49 p/Share
1,178 Reduced 10.98%
9,552 Common Stock
Feb 01 2021
BUY
Exercise of conversion of derivative security
-
3,020 Added 21.96%
10,730 Common Stock
Feb 01 2021
BUY
Grant, award, or other acquisition
$10,992 $41.17 p/Share
267 Added 3.35%
7,710 Common Stock
BEC

Brian Edwin Cathers

Chief Scientific Officer
South San Francisco, CA

Track Institutional and Insider Activities on GBT

Follow Global Blood Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GBT shares.

Notify only if

Insider Trading

Get notified when an Global Blood Therapeutics, Inc. insider buys or sells GBT shares.

Notify only if

News

Receive news related to Global Blood Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GBT